Double-blind, Randomised Study of A3384 in BAM/BAD

A Phase II, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of A3384 in Patients With Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD)

The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).

Inclusion Criteria:

• Patient meets protocol specified criteria for Bile Acid Malabsorption/Bile Acid Diarrhoea
• Patient has successfully completed study requirements with no clinically relevant findings for physical exam, ECG, laboratory tests as applicable

Exclusion Criteria:

• Medical history or medical condition that would not make the patient a good candidate for the study or limit the patient´s ability to complete the study
• Patient needs medications prohibited as specified in the protocol